Preliminary evaluation of 4-(2-N,N-dialkylaminoethyl)indoles as potential dopamine agonists

DOI: 10.1016/0223-5234(91)90110-9

Source and publish data:

European Journal of Medicinal Chemistry p. 473 - 475 (1991)

Update date:2022-08-04

Topics:

Authors:

Persons Persons

Mayer Mayer

Nichols Nichols

Cassady Cassady

Smalstig

Clemens Clemens

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/0223-5234(91)90110-9

Full text of DOI:10.1016/0223-5234(91)90110-9

Products guided by the article

Product name:[2-(1H-Indol-4-yl)-ethyl]-phenethyl-propyl-amine

Cas No:135922-63-3

R&D Labs maybe for 135922-63-3

Xi'an Yuri Solar Co., Ltd

website:https://www.yurisolar.com/en

Contact:86--18092602675

Address:No. 560, East Hangtian Road, Xi'an, China
Shanghai Yudiao Chemistry Technology Co.,Ltd

Contact:0086-18964703211

Address:Building NO.5, NO.218,Rongtian Road,ganxiang town,Jinshan District,shanghai,201518,china
QUZHOU ZIO I/E CO.;LTD

Contact:13357117572

Address:No.149 Shiji dadao Road.
Sinonine Industry Co.,Ltd

Contact:86+21-56421993

Address:3F,BUILDING 10,NO.2889 JINKE ROAD, SHANGHAI.
Hangzhou Ledun Technology Co.,Ltd.

Contact:86-571-18767088918

Address:No.6 street,XiaSha,Hangzhou,China.

Relevant to this article

Synthesis and evaluation of non-basic inhibitors of urokinase-type plasminogen activator (uPA)

Doi:10.1016/j.bmc.2011.12.040
(2012)
N -heterocyclic carbene catalyzed domino cyclization of propargylic alcohols and benzoyl isocyanates

Doi:10.1021/jo202102y
(2012)
Involvement of common intermediate 3-hydroxy-L-kynurenine in chromophore biosynthesis of quinomycin family antibiotics

Doi:10.1038/ja.2010.142
(2011)
Monosaccharide-responsive release of insulin from polymersomes of polyboroxole block copolymers at neutral pH

Doi:10.1021/ja211728x
(2012)
Replacing conventional carbon nucleophiles with electrophiles: Nickel-catalyzed reductive alkylation of aryl bromides and chlorides

Doi:10.1021/ja301769r
(2012)
Toward the selective delivery of chemotherapeutics into tumor cells by targeting peptide transporters: Tailored gold-based anticancer peptidomimetics

Doi:10.1021/jm201480u
(2012)

Article Doi